The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABSCI Corporation | COM | 00091E109 | 2,156,000 | 700,000 | SH | OTR | 700,000 | 0 | 0 | |||
| Akero Therapeutics Inc | COM | 00973Y108 | 39,336,156 | 1,676,733 | SH | OTR | 1,676,733 | 0 | 0 | |||
| Allogene Therapeutics Inc | COM | 019770106 | 8,970,500 | 3,850,000 | SH | OTR | 3,850,000 | 0 | 0 | |||
| Amylyx Pharmaceuticals Inc | COM | 03237H101 | 2,850,000 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | |||
| AnaptysBio Inc | COM | 032724106 | 32,578,000 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | |||
| Apellis Pharmaceuticals Inc | COM | 03753U106 | 66,209,360 | 1,726,000 | SH | OTR | 1,726,000 | 0 | 0 | |||
| Arcus Biosciences Inc | COM | 03969F109 | 24,401,506 | 1,602,200 | SH | OTR | 1,602,200 | 0 | 0 | |||
| Argenx SE | SPONSORED ADR | 04016X101 | 43,004,000 | 100,000 | SH | OTR | 100,000 | 0 | 0 | |||
| Arvinas Inc | COM | 04335A105 | 16,201,305 | 608,614 | SH | OTR | 608,614 | 0 | 0 | |||
| Atara Biotherapeutics Inc | COM | 046513107 | 1,411,000 | 166,000 | SH | OTR | 166,000 | 0 | 0 | |||
| Avidity Biosciences Inc | COM | 05370A108 | 70,563,800 | 1,727,388 | SH | OTR | 1,727,388 | 0 | 0 | |||
| Axsome Therapeutics Inc | COM | 05464T104 | 32,200,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | |||
| BeiGene Ltd | SPONSORED ADR | 07725L102 | 71,335,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | |||
| BioAtla Inc | COM | 09077B104 | 940,295 | 686,347 | SH | OTR | 686,347 | 0 | 0 | |||
| Black Diamond Therapeutics I | COM | 09203E105 | 2,357,960 | 506,000 | SH | OTR | 506,000 | 0 | 0 | |||
| Boundless Bio Inc | COM | 10170A100 | 2,752,843 | 711,329 | SH | OTR | 711,329 | 0 | 0 | |||
| Century Therapeutics Inc | COM | 15673T100 | 12,499,088 | 4,901,603 | SH | OTR | 4,901,603 | 0 | 0 | |||
| Cullinan Therapeutics Inc | COM | 230031106 | 11,473,689 | 657,895 | SH | OTR | 657,895 | 0 | 0 | |||
| Cytokinetics Inc | COM NEW | 23282W605 | 113,778,000 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | |||
| Day One Biopharmaceuticals I | COM | 23954D109 | 16,397,415 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | |||
| DBV Technologies S A | SPONSORED ADR | 23306J101 | 200,250 | 250,000 | SH | OTR | 250,000 | 0 | 0 | |||
| Engene Holdings Inc | COM | 29286M105 | 6,864,097 | 727,900 | SH | OTR | 727,900 | 0 | 0 | |||
| Enliven Therapeutics Inc | COM | 29337E102 | 15,689,636 | 671,358 | SH | OTR | 671,358 | 0 | 0 | |||
| Eliem Therapeutics Inc | COM | 28658R106 | 18,508,681 | 2,603,190 | SH | OTR | 2,603,190 | 0 | 0 | |||
| Fate Therapeutics Inc | COM | 31189P102 | 26,948,185 | 8,215,910 | SH | OTR | 8,215,910 | 0 | 0 | |||
| Geron Corp | COM | 374163103 | 25,440,000 | 6,000,000 | SH | OTR | 6,000,000 | 0 | 0 | |||
| Ideaya Biosciences Inc | COM | 45166A102 | 77,340,729 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | |||
| Immunovant Inc | COM | 45258J102 | 21,780,000 | 825,000 | SH | OTR | 825,000 | 0 | 0 | |||
| Iovance Biotherapeutics Inc | COM | 462260100 | 6,015,000 | 750,000 | SH | OTR | 750,000 | 0 | 0 | |||
| iTeos Therapeutics Inc | COM | 46565G104 | 43,732,219 | 2,946,915 | SH | OTR | 2,946,915 | 0 | 0 | |||
| Jasper Therapeutics Inc | COM NEW | 471871202 | 7,945,000 | 350,000 | SH | OTR | 350,000 | 0 | 0 | |||
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 18,730,200 | 1,590,000 | SH | OTR | 1,590,000 | 0 | 0 | |||
| Kura Oncology Inc | COM | 50127T109 | 20,590,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | |||
| Legend Biotech Corp | SPONSORED ADS | 52490G102 | 26,574,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | |||
| Merus N V | COM | N5749R100 | 112,423,000 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | |||
| Milestone Pharmaceuticals In | COM | 59935V107 | 407,889 | 309,007 | SH | OTR | 309,007 | 0 | 0 | |||
| Nkarta Inc | COM | 65487U108 | 33,139,439 | 5,607,350 | SH | OTR | 5,607,350 | 0 | 0 | |||
| Nuvalent Inc | COM | 670703107 | 84,977,765 | 1,120,192 | SH | OTR | 1,120,192 | 0 | 0 | |||
| Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 42,667 | 266,666 | SH | OTR | 266,666 | 0 | 0 | |||
| Olema Pharmaceuticals Inc | COM | 68062P106 | 7,033,000 | 650,000 | SH | OTR | 650,000 | 0 | 0 | |||
| Orchestra Biomed Hldgs Inc | COM | 68572M106 | 1,941,273 | 238,193 | SH | OTR | 238,193 | 0 | 0 | |||
| Oric Pharmaceuticals Inc | COM | 68622P109 | 12,249,277 | 1,732,571 | SH | OTR | 1,732,571 | 0 | 0 | |||
| Poseida Therapeutics | COM | 73730P108 | 13,067,000 | 4,475,000 | SH | OTR | 4,475,000 | 0 | 0 | |||
| Prelude Therapeutics Inc | COM | 74065P101 | 9,785,173 | 2,568,287 | SH | OTR | 2,568,287 | 0 | 0 | |||
| Protara Therapeutics Inc | COM STK | 74365U107 | 1,688,184 | 811,627 | SH | OTR | 811,627 | 0 | 0 | |||
| Prothena Corp PLC | SHS | G72800108 | 14,241,600 | 690,000 | SH | OTR | 690,000 | 0 | 0 | |||
| Relay Therapeutics Inc | COM | 75943R102 | 11,860,741 | 1,819,132 | SH | OTR | 1,819,132 | 0 | 0 | |||
| Replimune Group Inc | COM | 76029N106 | 13,827,069 | 1,536,341 | SH | OTR | 1,536,341 | 0 | 0 | |||
| Revolution Medicines Inc | COM | 76155X100 | 166,085,998 | 4,279,464 | SH | OTR | 4,279,464 | 0 | 0 | |||
| Rocket Pharmaceuticals Inc | COM | 77313F106 | 31,564,078 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | |||
| Sana Biotechnology Inc | COM | 799566104 | 8,435,700 | 1,545,000 | SH | OTR | 1,545,000 | 0 | 0 | |||
| Sarepta Therapeutics Inc | COM | 803607100 | 102,700,000 | 650,000 | SH | OTR | 650,000 | 0 | 0 | |||
| Springworks Therapeutics Inc | COM | 85205L107 | 128,889,449 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | |||
| Spyre Therapeutics Inc | COM NEW | 00773J202 | 16,374,245 | 696,480 | SH | OTR | 696,480 | 0 | 0 | |||
| Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 15,708,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | |||
| Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 1,107 | 66,666 | SH | OTR | 66,666 | 0 | 0 | |||
| Tango Therapeutics Inc | COM | 87583X109 | 70,344,348 | 8,198,642 | SH | OTR | 8,198,642 | 0 | 0 | |||
| Third Harmonic Bio Inc | COM | 88427A107 | 26,000,000 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | |||
| Tyra Biosciences Inc | COM | 90240B106 | 103,109,260 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | |||
| Xenon Pharmaceuticals Inc | COM | 98420N105 | 23,394,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | |||
| Zentalis Pharmaceuticals Inc | COM | 98943L107 | 1,840,500 | 450,000 | SH | OTR | 450,000 | 0 | 0 | |||